Sensitive ASX Announcement

FDA Type C Feedback, HEALEY trial potentially registrational

Published: 06/10/26, 09:57am (AEST)•2 pages
Neurizon Therapeutics
NUZ:ASX•Healthcare

Recent NUZ Announcements

Price Sensitive only